Pros And Cons Of FDA's Push For Nonprescription Drugs
Under the leadership of Commissioner Martin Makary, the U.S. Food and Drug Administration is looking to dramatically expand access to nonprescription — often referred to as over-the-counter, or OTC — drugs....To view the full article, register now.
Already a subscriber? Click here to view full article